Treating seizures and epilepsy with anticoagulants?

Frontiers in Cellular Neuroscience

Volumn , Issue FEB, 2013, Pages

  Maggio, Nicola ^a   Blatt, Ilan ^a,b   Vlachos, Andreas ^c   Tanne, David ^a,b   Chapman, Joab ^a,b   Segal, Menahem ^d  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c GOETHE UNIVERSITY   (Germany)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Blood brain barrier; Novel anticoagulants; PAR 1; Seizures; Thrombin

Indexed keywords

ANTICONVULSIVE AGENT; APIXABAN; DABIGATRAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 1 ANTAGONIST; RIVAROXABAN; THROMBIN; THROMBIN INHIBITOR; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN HEMORRHAGE; BRAIN TISSUE; CORPUS STRIATUM; DRUG EFFECT; DRUG EFFICACY; EPILEPSY; HIPPOCAMPUS; HUMAN; MEMBRANE DEPOLARIZATION; MOLECULAR PATHOLOGY; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84874164183     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00019     Document Type: Review

References (57)

1. Ahn, H.S., Chackalamannil, S., Boykow, G., Graziano, M.P., and Foster, C. (2003). Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseases. Curr Pharm Des 9, 2349-2365.
2. Almonte, A.G., Hamill, C.E., Chhatwal, J.P., Wingo, T.S., Barber, J.A., Lyuboslavsky, P.N., David Sweatt, J., Ressler, K.J., White, D.A., and Traynelis, S.F. (2007). Learning and memory deficits in mice lacking protease activated receptor-1. Neurobiol Learn Mem 88, 295-304.
3. Almonte, A.G., Qadri, L.H., Sultan, F.A., Watson, J.A., Mount, D.J., Rumbaugh, G., and Sweatt, J.D. (2013). Protease-activated receptor-1 modulates hippocampal memory formation and synaptic plasticity. J Neurochem 124, 109-122.
4. Ballabh, P., Braun, A., and Nedergaard, M. (2004). The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16, 1-13.
5. Bang, O.Y., Saver, J.L., Alger, J.R., Shah, S.H., Buck, B.H., Starkman, S., Ovbiagele, B., and Liebeskind, D.S. (2009). Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke 40, 454-461.
6. Barzo, P., Marmarou, A., Fatouros, P., Hayasaki, K., and Corwin, F. (1997). Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosurg 87, 900-907.
7. Beart, P.M., and O'shea, R.D. (2007). Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150, 5-17.
8. Beilin, O., Karussis, D.M., Korczyn, A.D., Gurwitz, D., Aronovich, R., Hantai, D., Grigoriadis, N., Mizrachi-Kol, R., and Chapman, J. (2005). Increased thrombin inhibition in experimental autoimmune encephalomyelitis. J Neurosci Res 79, 351-359.
9. Boven, L.A., Vergnolle, N., Henry, S.D., Silva, C., Imai, Y., Holden, J., Warren, K., Hollenberg, M.D., and Power, C. (2003). Up-regulation of proteinaseactivated receptor 1 expression in astrocytes during HIV encephalitis. J Immunol 170, 2638-2646.
10. Chapman, J. (2006). Thrombin in inflammatory brain diseases. Autoimmun Rev 5, 528-531.
11. Chen, D., and Dorling, A. (2009). Critical roles for thrombin in acute and chronic inflammation. J Thromb Haemost 7 Suppl 1, 122-126.
12. Chen, Y., and Swanson, R.A. (2003). Astrocytes and brain injury. J Cereb Blood Flow Metab 23, 137-149.
13. Chodobski, A., Zink, B.J., and Szmydynger-Chodobska, J. (2011). Blood-brain barrier pathophysiology in traumatic brain injury. Transl Stroke Res 2, 492-516.
14. Coughlin, S.R. (2000). Thrombin signalling and protease-activated receptors. Nature 407, 258-264.
15. Coughlin, S.R. (2001). Protease-activated receptors in vascular biology. Thromb Haemost 86, 298-307.
16. Dentali, F., Riva, N., Crowther, M., Turpie, A.G., Lip, G.Y., and Ageno, W. (2012). Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature. Circulation 126, 2381-2391.
17. Gingrich, M.B., Junge, C.E., Lyuboslavsky, P., and Traynelis, S.F. (2000). Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci 20, 4582-4595.
18. Gingrich, M.B., and Traynelis, S.F. (2000). Serine proteases and brain damage-is there a link? Trends Neurosci 23, 399-407.
19. Goldstone, A.B., Bronster, D.J., Anyanwu, A.C., Goldstein, M.A., Filsoufi, F., Adams, D.H., and Chikwe, J. (2011a). Predictors and outcomes of seizures after cardiac surgery: a multivariable analysis of 2,578 patients. Ann Thorac Surg 91, 514-518.
20. Goldstone, A.B., Bronster, D.J., and Chikwe, J. (2011b). Seizures after adult cardiac surgery. J Cardiothorac Vasc Anesth 25, e25-26.
21. Haft, J.I. (2012). Stroke Prevention in Atrial Fibrillation: Impact of Novel Oral Anticoagulants. Clin Appl Thromb Hemost.
22. Heinemann, U. (2004). Basic mechanisms of partial epilepsies. Curr Opin Neurol 17, 155-159.
23. Heinemann, U., Buchheim, K., Gabriel, S., Kann, O., Kovacs, R., and Schuchmann, S. (2002). Cell death and metabolic activity during epileptiform discharges and status epilepticus in the hippocampus. Prog Brain Res 135, 197-210.
24. Hervey-Jumper, S.L., Annich, G.M., Yancon, A.R., Garton, H.J., Muraszko, K.M., and Maher, C.O. (2011). Neurological complications of extracorporeal membrane oxygenation in children. J Neurosurg Pediatr 7, 338-344.
25. Hjort, N., Wu, O., Ashkanian, M., Solling, C., Mouridsen, K., Christensen, S., Gyldensted, C., Andersen, G., and Ostergaard, L. (2008). MRI detection of early blood-brain barrier disruption: parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis. Stroke 39, 1025-1028.
26. Isaeva, E., Hernan, A., Isaev, D., and Holmes, G.L. (2012). Thrombin facilitates seizures through activation of persistent sodium current. Ann Neurol 72, 192-198.
27. Ishida, Y., Nagai, A., Kobayashi, S., and Kim, S.U. (2006). Upregulation of proteaseactivated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase. J Neuropathol Exp Neurol 65, 66-77.
28. Junge, C.E., Lee, C.J., Hubbard, K.B., Zhang, Z., Olson, J.J., Hepler, J.R., Brat, D.J., and Traynelis, S.F. (2004). Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes. Exp Neurol 188, 94-103.
29. Kelly, K.M. (2008). Thrombin: is it on a par with seizures and epilepsy? Epilepsy Curr 8, 110-112.
30. Landis, C. (2007). Why thrombin PAR1 receptors are important to the cardiac surgical patient. J Extra Corpor Technol 39, 305-307.
31. Lee, C.J., Mannaioni, G., Yuan, H., Woo, D.H., Gingrich, M.B., and Traynelis, S.F. (2007). Astrocytic control of synaptic NMDA receptors. J Physiol 581, 1057-1081.
32. Lee Da, Y., Park, K.W., and Jin, B.K. (2006). Thrombin induces neurodegeneration and microglial activation in the cortex in vivo and in vitro: proteolytic and non-proteolytic actions. Biochem Biophys Res Commun 346, 727-738.
33. Lee, H., and Hamilton, J.R. (2012). Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular disease. Pharmacol Ther 134, 246-259.
34. Lee, K.R., Drury, I., Vitarbo, E., and Hoff, J.T. (1997). Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J Neurosurg 87, 73-78.
35. Lippi, G., Franchini, M., Montagnana, M., and Favaloro, E.J. (2012). Inherited disorders of blood coagulation. Ann Med 44, 405-418.
36. Luo, W., Wang, Y., and Reiser, G. (2007). Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Res Rev 56, 331-345.
37. Luthi, A., Van Der Putten, H., Botteri, F.M., Mansuy, I.M., Meins, M., Frey, U., Sansig, G., Portet, C., Schmutz, M., Schroder, M., Nitsch, C., Laurent, J.P., and Monard, D. (1997). Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation. J Neurosci 17, 4688-4699.
38. Maggio, N., Cavaliere, C., Papa, M., Blatt, I., Chapman, J., and Segal, M. (2012). Thrombin regulation of synaptic transmission: Implications for seizure onset. Neurobiol Dis 50C, 171-178.
39. Maggio, N., Shavit, E., Chapman, J., and Segal, M. (2008). Thrombin induces longterm potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults. J Neurosci 28, 732-736.
40. Nitsch, C., and Klatzo, I. (1983). Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents. J Neurol Sci 59, 305-322.
41. Pisapia, J.M., Xu, X., Kelly, J., Yeung, J., Carrion, G., Tong, H., Meghan, S., El-Falaky, O.M., Grady, M.S., Smith, D.H., Zaitsev, S., Muzykantov, V.R., Stiefel, M.F., and Stein, S.C. (2012). Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan. Exp Neurol 233, 357-363.
42. Pompili, E., Nori, S.L., Geloso, M.C., Guadagni, E., Corvino, V., Michetti, F., and Fumagalli, L. (2004). Trimethyltin-induced differential expression of PAR subtypes in reactive astrocytes of the rat hippocampus. Brain Res Mol Brain Res 122, 93-98.
43. Sambrano, G.R., Weiss, E.J., Zheng, Y.W., Huang, W., and Coughlin, S.R. (2001). Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 413, 74-78.
44. Schuepbach, R.A., Feistritzer, C., Fernandez, J.A., Griffin, J.H., and Riewald, M. (2009). Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Thromb Haemost 101, 724-733.
45. Siller-Matula, J.M., Schwameis, M., Blann, A., Mannhalter, C., and Jilma, B. (2011). Thrombin as a multi-functional enzyme. Focus on in vitro and in vivo effects. Thromb Haemost 106, 1020-1033.
46. Spiel, A.O., Bartko, J., Schwameis, M., Firbas, C., Siller-Matula, J., Schuetz, M., Weigl, M., and Jilma, B. (2011). Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial. Thromb Haemost 105, 655-662.
47. Stein, S.C., Chen, X.H., Sinson, G.P., and Smith, D.H. (2002). Intravascular coagulation: a major secondary insult in nonfatal traumatic brain injury. J Neurosurg 97, 1373-1377.
48. Striggow, F., Riek-Burchardt, M., Kiesel, A., Schmidt, W., Henrich-Noack, P., Breder, J., Krug, M., Reymann, K.G., and Reiser, G. (2001). Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur J Neurosci 14, 595-608.
49. Striggow, F., Riek, M., Breder, J., Henrich-Noack, P., Reymann, K.G., and Reiser, G. (2000). The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci U S A 97, 2264-2269.
50. Suzuki, M., Ogawa, A., Sakurai, Y., Nishino, A., Venohara, K., Mizoi, K., and Yoshimoto, T. (1992). Thrombin activity in cerebrospinal fluid after subarachnoid hemorrhage. Stroke 23, 1181-1182.
51. Tomkins, O., Friedman, O., Ivens, S., Reiffurth, C., Major, S., Dreier, J.P., Heinemann, U., and Friedman, A. (2007). Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis 25, 367-377.
52. Tomkins, O., Kaufer, D., Korn, A., Shelef, I., Golan, H., Reichenthal, E., Soreq, H., and Friedman, A. (2001). Frequent blood-brain barrier disruption in the human cerebral cortex. Cell Mol Neurobiol 21, 675-691.
53. Tomkins, O., Shelef, I., Kaizerman, I., Eliushin, A., Afawi, Z., Misk, A., Gidon, M., Cohen, A., Zumsteg, D., and Friedman, A. (2008). Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry 79, 774-777.
54. Wang, Y., Luo, W., Stricker, R., and Reiser, G. (2006). Protease-activated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1. J Neurochem 98, 1046-1060.
55. Wielders, S.J., Bennaghmouch, A., Reutelingsperger, C.P., Bevers, E.M., and Lindhout, T. (2007). Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists. J Thromb Haemost 5, 571-576.
56. Xi, G., Keep, R.F., and Hoff, J.T. (2006). Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 5, 53-63.
57. Zikria, J.C., and Ansell, J. (2009). Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change. Curr Opin Hematol 16, 347-356.